SG Americas Securities
LABU icon

SG Americas Securities’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

SG Americas Securities’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-701
Closed -$112K – 3479
2025
Q4 		$112K Sell
701
-2,910
-81% -$400K ﹤0.01% 3192
2025
Q3 		$338K Buy
3,611
+50
+1% +$3.53K ﹤0.01% 2401
2025
Q2 		$203K Buy
3,561
+635
+22% +$33.7K ﹤0.01% 2250
2025
Q1 		$178K Sell
2,926
-466
-14% -$39.7K ﹤0.01% 2618
2024
Q4 		$305K Buy
3,392
+193
+6% +$22.7K ﹤0.01% 1782
2024
Q3 		$412K Buy
3,199
+1,057
+49% +$138K ﹤0.01% 1862
2024
Q2 		$243K Buy
2,142
+970
+83% +$104K ﹤0.01% 2077
2024
Q1 		$156K Sell
1,172
-356
-23% -$46.5K ﹤0.01% 2169
2023
Q4 		$186K Sell
1,528
-155
-9% -$11.9K ﹤0.01% 2234
2023
Q3 		$128K Sell
1,683
-2,258
-57% -$232K ﹤0.01% 2622
2023
Q2 		$467K Buy
3,941
+2,414
+158% +$301K ﹤0.01% 1427
2023
Q1 		$150K Buy
+1,527
New +$207K ﹤0.01% 2643

Other funds holding LABU

Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
JF
Jump Financial Chicago, Illinois $7.5B AUM 33.9% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
MIG
McGuire Investment Group Wakefield, Rhode Island $885M AUM 47.78% 1-Year Est. Return
Belvedere Trading
Belvedere Trading Chicago, Illinois $84.4B AUM 52.68% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return

SG Americas Securities's LABU Position: Q1 2026 in Review

SG Americas Securities sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 701 shares — an estimated $112K sold.

SG Americas Securities first reported a position in LABU in Q1 2023 and held it in 12 quarters. The position peaked at $467K in Q2 2023. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

  • SG Americas Securities reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
  • SG Americas Securities sold 701 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $112K.
  • SG Americas Securities first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and held it in 12 quarters.
  • SG Americas Securities's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $467K in Q2 2023.
  • 33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on SG Americas Securities's 13F filing for Q1 2026, filed 16 Apr 2026.